HSBC Holdings plc Sponsored ADR (HSBC)
HSBC Posts Sharply Higher Quarterly Profit, Plans $1 Billion Share Buyback
The London-based bank said its second-quarter net profit jumped 68% from a year earlier to $7.69 billion and announced a share buyback of up to $1 billion.
HSBC's first-half profit jumps 23%
HSBC Holdings reported a 23% first-half profit surge on Tuesday, as rising net interest income and revenue from wealth management pushed up fee income on robust money and deal flows.
Why HSBC is Scaling Back Retail Banking in Egypt and Australia
HSBC is exiting retail banking in Egypt and Australia to cut complexity, boost efficiency and shift capital toward higher-return global franchises.
HSBC to Divest Singapore Insurance Unit to Allianz for $2.09B
HSBC is set to sell its Singapore insurance unit to Allianz for $2.09B, advancing simplification while retaining insurance distribution through a 15-year deal.
HSBC Warns: Brutal Commodity ‘Super-Squeeze' Coming as Iran Conflict Widens
For much of the past year, global markets have absorbed geopolitical shocks with surprising resilience.
HSBC sells Singapore life business to Allianz
HSBC Holdings PLC (LSE:HSBA) has offloaded its Singapore life and health insurance business to Germany's Allianz for US$2.1 billion (£1.6 billion), as part of the bank's ongoing simplification programme. The disposal of HSBC Life Singapore is expected to generate a pre-tax gain of US$1.8 billion and add up to 15 basis points to the group's common equity tier one capital ratio.
HSBC to Sell Singapore Insurance Business to Allianz for $2.1 Billion
HSBC and Allianz will enter into an exclusive 15-year bancassurance partnership on completion of the deal that would allow HSBC to continue distributing insurance products to its Singapore customers.
HSBC (HSBC) Is Up 1.53% in One Week: What You Should Know
Does HSBC (HSBC) have what it takes to be a top stock pick for momentum investors? Let's find out.
Arm stock falls 6% as HSBC cites foundry bottlenecks, cuts rating to Hold
Arm Holdings shares fell more than 6% on Tuesday after HSBC downgraded the chip designer to Hold, saying foundry capacity constraints are likely to limit earnings upside despite the company's strong long-term growth prospects. The brokerage still raised its price target to $315 from $255.
HSBC downgrades AstraZeneca after key trial failure
HSBC has downgraded AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) to 'hold' from 'buy', arguing that a recent trial failure has removed the central pillar of its bull case and left a tougher path ahead. The bank cut its target price to 13,750p from 16,500p, implying limited upside.
HSBC Tightens Private Credit Strategy Amid Rising Sector Concerns
HSBC is tightening private credit exposure by limiting higher-risk fund financing, sharpening its focus on disciplined lending and risk-adjusted returns.
‘We anticipate further upside for gold by year-end' – HSBC's Sels and Ku
Even as U.S. Treasury yields and a stronger dollar continue to limit gold's upside, growing diversification demand, central bank buying and ETF inflows should support further price gains for the yellow metal by the end of 2026, according to HSBC.
